136 related articles for article (PubMed ID: 28418283)
1. Serum Bilirubin Concentrations in Patients With Takayasu Arteritis.
Peng YF; Deng YB
Arch Pathol Lab Med; 2017 Jun; 141(6):846-850. PubMed ID: 28418283
[TBL] [Abstract][Full Text] [Related]
2. The role of mean platelet volume in patients with Takayasu arteritis.
Peng YF; Guo J; Deng YB
Ann Clin Biochem; 2017 Mar; 54(2):273-278. PubMed ID: 27329216
[TBL] [Abstract][Full Text] [Related]
3. Profiles of serum cytokine levels in Takayasu arteritis patients: Potential utility as biomarkers for monitoring disease activity.
Tamura N; Maejima Y; Tezuka D; Takamura C; Yoshikawa S; Ashikaga T; Hirao K; Isobe M
J Cardiol; 2017 Sep; 70(3):278-285. PubMed ID: 27989502
[TBL] [Abstract][Full Text] [Related]
4. Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis.
Tombetti E; Di Chio MC; Sartorelli S; Papa M; Salerno A; Bottazzi B; Bozzolo EP; Greco M; Rovere-Querini P; Baldissera E; Del Maschio A; Mantovani A; De Cobelli F; Sabbadini MG; Manfredi AA
Arthritis Res Ther; 2014 Nov; 16(6):479. PubMed ID: 25394473
[TBL] [Abstract][Full Text] [Related]
5. High Levels of Circulating Endothelial Progenitor Cells Are Associated with Acrotism in Patients with Takayasu Arteritis.
Keşkek ŞÖ; Bozkırlı-Ersözlü ED; Kozanoglu I; Yücel AE
Med Princ Pract; 2017; 26(2):132-138. PubMed ID: 27816980
[TBL] [Abstract][Full Text] [Related]
6. Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences.
Tezuka D; Haraguchi G; Ishihara T; Ohigashi H; Inagaki H; Suzuki J; Hirao K; Isobe M
JACC Cardiovasc Imaging; 2012 Apr; 5(4):422-9. PubMed ID: 22498333
[TBL] [Abstract][Full Text] [Related]
7. Function of N-terminal pro-brain natriuretic peptide in Takayasu arteritis disease monitoring.
Liu Q; Dang A; Chen B; Lv N; Wang X; Zheng D
J Rheumatol; 2014 Aug; 41(8):1683-8. PubMed ID: 25028376
[TBL] [Abstract][Full Text] [Related]
8. NMR-Based Serum Metabolomics of Patients with Takayasu Arteritis: Relationship with Disease Activity.
Jain A; Kumar D; Guleria A; Misra DP; Zanwar A; Chaurasia S; Kumar S; Kumar U; Mishra SK; Goel R; Danda D; Misra R
J Proteome Res; 2018 Sep; 17(9):3317-3324. PubMed ID: 30095916
[TBL] [Abstract][Full Text] [Related]
9. Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study.
de Souza AW; da Silva MD; Machado LS; Oliveira AC; Pinheiro FA; Sato EI
Scand J Rheumatol; 2012 May; 41(3):227-30. PubMed ID: 22400913
[TBL] [Abstract][Full Text] [Related]
10. Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis.
Kong X; Xu M; Cui X; Ma L; Cheng H; Hou J; Sun X; Ma L; Jiang L
Front Immunol; 2021; 12():646516. PubMed ID: 34079541
[TBL] [Abstract][Full Text] [Related]
11. Value of contrast-enhanced ultrasonography of the carotid artery for evaluating disease activity in Takayasu arteritis.
Ma LY; Li CL; Ma LL; Cui XM; Dai XM; Sun Y; Chen HY; Huang BJ; Jiang LD
Arthritis Res Ther; 2019 Jan; 21(1):24. PubMed ID: 30651132
[TBL] [Abstract][Full Text] [Related]
12. Reduced ovarian reserve in patients with Takayasu arteritis.
Mont'Alverne AR; Pereira RM; Yamakami LY; Viana VS; Baracat EC; Bonfá E; Silva CA
J Rheumatol; 2014 Oct; 41(10):2055-9. PubMed ID: 25128515
[TBL] [Abstract][Full Text] [Related]
13. Circulatory Glutamine/Glucose ratio for evaluating disease activity in Takayasu arteritis: A NMR based serum metabolomics study.
Kumar U; Jain A; Guleria A; R VK; Misra DP; Goel R; Danda D; Misra R; Kumar D
J Pharm Biomed Anal; 2020 Feb; 180():113080. PubMed ID: 31896520
[TBL] [Abstract][Full Text] [Related]
14. Are monocyte-to-HDL and C-reactive protein-to-albumin ratios useful for the diagnosis and follow-up of Takayasu arteritis?
Kılınç EA; Varkal G; Kırmızıer G; Türk İ; Özer HTE
Rev Assoc Med Bras (1992); 2024; 70(5):e20231683. PubMed ID: 38775535
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of fetuin-A as a novel biomarker for disease activity in patients with Takayasu arteritis and granulomatous polyangiitis.
Karadeniz H; Güler AA; Koca G; Salman RB; Satış H; Ataş N; Babaoğlu H; Paşaoğlu H; Küçük H; Tufan A; Öztürk MA; Göker B; Haznedaroğlu Ş
Clin Rheumatol; 2022 Apr; 41(4):1169-1176. PubMed ID: 35013833
[TBL] [Abstract][Full Text] [Related]
16. Study of serial serum myeloid-related protein 8/14 as a sensitive biomarker in Takayasu arteritis: a single centre study.
Goel R; Nair A; Kabeerdoss J; Mohan H; Jeyaseelan V; Joseph G; Danda D
Rheumatol Int; 2018 Apr; 38(4):623-630. PubMed ID: 29196802
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
Mekinian A; Comarmond C; Resche-Rigon M; Mirault T; Kahn JE; Lambert M; Sibilia J; Néel A; Cohen P; Hie M; Berthier S; Marie I; Lavigne C; Anne Vandenhende M; Muller G; Amoura Z; Devilliers H; Abad S; Hamidou M; Guillevin L; Dhote R; Godeau B; Messas E; Cacoub P; Fain O; Saadoun D;
Circulation; 2015 Nov; 132(18):1693-700. PubMed ID: 26354797
[TBL] [Abstract][Full Text] [Related]
18. Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis.
Park MC; Lee SW; Park YB; Lee SK
Rheumatology (Oxford); 2006 May; 45(5):545-8. PubMed ID: 16352633
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of BAFF for assessing the disease activity of Takayasu arteritis.
Nishino Y; Tamai M; Kawakami A; Koga T; Makiyama J; Maeda Y; Jiuchi Y; Miyashita T; Izumi Y; Eguchi K; Migita K
Clin Exp Rheumatol; 2010; 28(1 Suppl 57):14-7. PubMed ID: 20412696
[TBL] [Abstract][Full Text] [Related]
20. Serum amyloid A as a marker of disease activity and treatment response in Takayasu arteritis.
Nair AM; Goel R; Hindhumati M; Jayakanthan K; Visalakshi J; Joseph G; Danda S; Danda D
Rheumatol Int; 2017 Oct; 37(10):1643-1649. PubMed ID: 28801814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
